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Abstract
Background: Next Generation Sequencing (NGS) is a commonly used technology for studying the genetic basis of
biological processes and it underpins the aspirations of precision medicine. However, there are significant
challenges when dealing with NGS data. Firstly, a huge number of bioinformatics tools for a wide range of uses
exist, therefore it is challenging to design an analysis pipeline. Secondly, NGS analysis is computationally intensive,
requiring expensive infrastructure, and many medical and research centres do not have adequate high performance
computing facilities and cloud computing is not always an option due to privacy and ownership issues. Finally, the
interpretation of the results is not trivial and most available pipelines lack the utilities to favour this crucial step.
Results: We have therefore developed a fast and efficient bioinformatics pipeline that allows for the analysis of
DNA sequencing data, while requiring little computational effort and memory usage. DNAscan can analyse a whole
exome sequencing sample in 1 h and a 40x whole genome sequencing sample in 13 h, on a midrange computer.
The pipeline can look for single nucleotide variants, small indels, structural variants, repeat expansions and viral
genetic material (or any other organism). Its results are annotated using a customisable variety of databases and are
available for an on-the-fly visualisation with a local deployment of the gene.iobio platform. DNAscan is
implemented in Python. Its code and documentation are available on GitHub: https://github.com/KHP-Informatics/
DNAscan. Instructions for an easy and fast deployment with Docker and Singularity are also provided on GitHub.
Conclusions: DNAscan is an extremely fast and computationally efficient pipeline for analysis, visualization and
interpretation of NGS data. It is designed to provide a powerful and easy-to-use tool for applications in biomedical
research and diagnostic medicine, at minimal computational cost. Its comprehensive approach will maximise the
potential audience of users, bringing such analyses within the reach of non-specialist laboratories, and those from
centres with limited funding available.
Keywords: Bioinformatics, Variant calling, Viral detection, Repeat expansion, Structural variants, Annotation, Next
generation sequencing
Background
The generation of whole genome sequencing (WGS),
whole exome sequencing (WES) or targeted gene panels,
is now standard practice in biomedical research. On a
large scale, international sequencing consortia study the
genetic landscape of thousands of individuals. On an
individual scale, sequencing data are also used in diag-
nostic medicine and so called Precision Medicine [1, 2],
with the aim to tailor medical treatments to patient
genetics. There are several practical challenges when
processing next generation sequencing (NGS) data. For
example, WGS data for one sample produced on the
Illumina Hiseq X, one of the most popular sequencers,
is about 100 gigabytes, allowing for a high depth of se-
quencing (average 40x), when stored using lossless com-
pressed formats such as fastq.gz. Such large files are not
easy to handle for the average non-specialised scientist
or lab, since they require sophisticated tools, bioinfor-
matics skills and high performance computing clusters
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for analysis. While such facilities are available in special-
ist, well-resourced centres in wealthy countries, they are
not readily accessible in other settings. Cloud computing
provides a solution for the computing aspect of the chal-
lenge, but not the cost or the specialist skills needed.
Furthermore, privacy requirements, ownership policies,
and lack of an adequate internet infrastructure can make
their use impractical.
A further significant issue is the large number of bio-
informatics tools available for NGS analysis. Omictools
[3], a web database where most available tools are listed
and reviewed, lists over 7000 bioinformatics NGS tools,
and new ones are frequently released. Among these
more than 100 analysis pipelines are listed, most of
which do not cover the whole data analysis, annotation
and visualisation process and are computationally more
intensive. For example, SpeedSeq [4] and GATK Best
Practise Workflow [5] (GATK BPW) are two of the most
popular. While these pipelines guarantee a very high
genotyping quality, their use requires high-performance
computing facilities and specialized expertise. What is
needed therefore is a single pipeline, able to be deployed
by someone without training in bioinformatics, and able
to run on readily available computing equipment, easily
accessible to non-specialist labs in any part of the world.
Here we describe DNAscan, an extremely fast, accur-
ate and computationally light bioinformatics pipeline for
the analysis, annotation and visualisation of DNA next
generation (short-reads) sequencing data. DNAscan is
designed to provide a powerful and easy-to-use tool for
applications in biomedical research and diagnostic medi-
cine, at minimal computational cost. The pipeline can
analyse 40x WGS data in 13 h using 4 threads and 16
Gb RAM and WES data in 1 h using 4 threads and 10.5
Gb of RAM, and detect SNVs, small indels, structural
variants, repeat expansions and viral genetic material (or
that of any other microbe, e.g. bacteria and fungi). Re-
sults are annotated using a variety of databases and
made available for a local deployment of the gene.iobio
platform for an on-the-fly visualisation. Additionally,




The DNAscan pipeline consists of four stages: Align-
ment, Analysis, Annotation and Report generation, and
can be run in three modes: Fast, Normal and Intensive,
according to user requirements (Fig. 1 and Table 1).
These modes have been designed to optimize computa-
tional effort without compromising performance for the
type of genetic variant the user is testing (see mode rec-
ommendations in Table 2). The user can restrict the
analysis to any sub-region of the human genome by
proving either a region file in bed format, a list of gene
names, or using the whole-exome option, reducing the
processing time and generating region specific reports.
Alignment
DNAscan accepts sequencing data in fastq.gz and as a Se-
quence Alignment Map (SAM) file (and its compressed
version BAM). HISAT2 and BWA mem [6, 7] are used to
map the reads to the reference genome (Fig. 1, left panel).
This step is skipped if the user provides data in SAM or
BAM formats. HISAT2 is a fast and sensitive alignment
program for mapping next-generation sequencing reads to
a reference genome. HISAT2 uses a new reference index-
ing scheme called a Hierarchical Graph FM index
(HGFM) [8], thanks to which it can guarantee a high per-
formance, comparable to state-of-the-art tools, in approxi-
mately one quarter of the time of BWA and Bowtie2 [9]
(see Additional file 1).
Variant calling pipelines based on HISAT2 generally
perform poorly on indels [10]. To address this issue,
DNAscan uses BWA to realign soft-clipped and un-
aligned reads. This alignment refinement step is skipped
if DNAscan is run in Fast mode.
Samblaster [11] is used to mark duplicates during the
alignment step and Sambamba [12] to sort the aligned
reads. Both the variant callers, Freebayes [13] and GATK
Haplotype Caller (HC) [5] used in the following step, are
duplicate-aware, meaning that they automatically ignore
reads marked as duplicate. The user can optionally ex-
clude it from the workflow according to the study de-
sign, e.g. when an intensive Polymerase Chain Reaction
(PCR) amplification of small regions is required.
Analysis
Various analyses are performed on the mapped sequen-
cing data (Fig. 1, right panel): SNV and small indel call-
ing is performed using Freebayes, whose reliability is
well reported [14, 15]. However, taking advantage of the
documented better performance of GATK HC in small
indel calling, we decided to add a customised indel call-
ing step to DNAscan, called Intensive mode. This step
firstly extracts the genome positions for which an inser-
tion or a deletion is present on the cigar of at least one
read, and secondly calls indels using GATK HC on these
selected positions. The reduced number of positions
where this occurs allows for a targeted use of GATK
HC, limiting the required computational effort and time.
The resulting SNVs and small indel calls with genotype
quality smaller then 20 and depth smaller than 10 are
discarded. The user can customize these filters according
to their needs (see GitHub [16] for details and a
complete list of available filters).
Two Illumina developed tools, Manta [17] and Expan-
sion Hunter [18] are used for detecting medium and
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large structural variants (> 50 bp) including insertions,
deletions, translocations, duplications and known re-
peat expansions. These tools are optimised for high
speed and can analyse a 40x WGS sample in about
one hour using 4 threads, maintaining a very high
performance.
DNAscan also has options to scan the sequencing data
for microbial genetic material. It performs a computa-
tional subtraction of human host sequences to identify
sequences of infectious agents including viruses, bacteria
or fungi, by aligning the non-human or unaligned reads
to the whole NCBI database [19–21] of known viral,
Fig. 1 Pipeline overview. Central panel: DNAscan accepts sequencing data, and optionally variant files. The pipeline firstly performs an alignment
step (details in the left panel), followed by a customisable data analysis protocol (details in the right panel). Finally, results are annotated and
user-friendly QC and result reports are generated. The annotation step uses Annovar to enrich the results with functional information from
external databases. Right panel: detailed description of the post alignment analysis pipeline. Aligned reads are used by the variant calling pipeline
(Freebayes + GATK HC); both aligned and unaligned reads are used by Manta and ExpensionHunter (for which repeat description files have to be
provided) to look for structural variants. The unaligned reads are mapped to a database of known viral genomes (NCBI database) to screen for
their DNA in the input sequencing data. Left panel: Alignment stage description. Raw reads are aligned with HISAT2. Resulting soft-clipped and
unaligned reads are realigned with BWA mem and then merged with the others using Samtools
Table 1 Key tools used by DNAscan in the three modes
Stage DNAscan mode
Fast Normal Intensive
Alignment HISAT2 HISAT2 + BWA mem HISAT2 + BWA mem
SNVs calling Freebayes Freebayes Freebayes
Small indels calling Freebayes Freebayes GATK HC
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bacterial or any custom set of microbial genomes and
reporting the number of reads aligned to each
non-human genome, its length and the number of bases
covered by at least one read.
Annotation
Variant calls are then annotated using Annovar [22]. The
annotation includes the use of databases such as ClinVar
[23], Exac [24], dbSNP [25] and dbNSFP [26] (more infor-
mation about how to customise the annotation, e.g. by
selecting alternative databases and/or focusing on specific
genome regions, are available on GitHub).
Reports and visualization utilities
DNAscan produces a wide set of quality control (QC)
and result reports and provides utilities for visualisation
and interpretation of the results.
MultiQC [27] is used to wrap up and visualise QC re-
sults. FastQC [28], Samtools [29] and Bcftools [30] are
used to perform QC on the sequencing data, its align-
ment and the called variants. An example is available on
GitHub [31]. A tab delimited file including all variants
found within the selected region is also generated [32].
This report would include all annotations performed by
Annovar [22] in a format that is easy to handle with any
Excel-like software by users of all levels of expertise.
Three iobio services (bam.iobio, vcf.iobio and gene.io-
bio) are locally provided with the pipeline allowing for
the visualisation of the alignment file [33], the called var-
iants [34] and for a gene based visualisation and inter-
pretation of the results [35].
DNAscan benchmark
Benchmarking every DNAscan component is not needed
since a range of literature is available [14, 15, 17, 36, 37].
However, to our knowledge, none exists assessing
HISAT2 [8] (the short-read mapper used by the pipeline)
either for DNA read mapping or as part of DNA variant
calling pipelines. In this manuscript, we both assess the
performance of HISAT2 with BWA and Bowtie2 [9]
mapping 1.25 billion WGS reads sequenced with the
Illumina Hiseq X and 150 million simulated reads (see
Additional file 1), and compare our SNV/indel calling
pipeline in Fast, Normal and Intensive modes with the
GATK BPW [5] and SpeedSeq [4] over the whole exome
sequencing of NA12878. Illumina platinum calls are
used as true positives [38].
We also show how DNAscan represents a powerful
tool for medical and scientific use by analysing real
DNA sequence data from two patients affected by
Amyotrophic Lateral Sclerosis (ALS) and of HIV in-
fected human cells. For the ALS patients we use both a
gene panel of 10 ALS-related genes, whose feasibility for
diagnostic medicine has been previously investigated [2],
sequenced with the Illumina Miseq platform, and the
WGS data from the Project MinE sequencing dataset
[39]. DNAscan was used to look for SNVs, small indels,
structural variants, and known repeat expansions. The
WGS of an HIV infected human cell sample [40] was
used to test DNAscan for virus detection.
Variant calling assessment
To assess the performance of DNAscan in calling SNVs
and indels, we used the Illumina Genome Analyzer II
whole exome sequencing of NA12878. Illumina plat-
inum calls [38] were used as true positives.
GATK BPW calls were generated using default param-
eters and following the indications on the GATK website
[41] for germline SNVs and indels calling. These include
the pre-processing and variant discovery steps for single
sample, i.e. skipping the Merge and Join Genotype steps.
SpeedSeq calls were generated running the “align” and
“var” commands as described on GitHub [42]. RTG
Tools [43] (“vcfeval” command) was used to evaluate the
calls. F-measure, Precision and Sensitivity are defined as
in the following: Precision ¼ TpTpþFp , Sensitivity ¼
Tp
TpþFn
and F−measure ¼ 2 PrecisionSensitivityPrecisionþSensitivity , where Tp is true
positives, Fp false positives and Fn false negatives.
ALS Miseq and whole genome sequencing test cases
Using DNAscan in Fast mode, we analysed real DNA se-
quence data from two ALS patients (case A and case B).
Case A carries a non-synonymous mutation in the FUS
gene [44] (variant C1561T, amino acid change R521C,
variant dbSNP id rs121909670 [45]) known to be a cause
of ALS (ClinVar id RCV000017611.25). A panel of 10 ALS
related genes was sequenced with the Illumina Miseq plat-
form for case A. The Miseq gene panel was designed and
tested for diagnostic purposes [2]. For these 10 genes
(BSCL2, CEP112, FUS, MATR3, OPTN, SOD1, SPG11,
TARDBP, UBQLN2, and VCP), the full exon set was se-
quenced, generating over 825,000,222-base-long paired
reads. DNAscan was used to call SNVs, indels, and struc-
tural variants on case A.
Case B has a confirmed C9orf72 expansion mutation
on one allele, also known to be causative of ALS [46].
This expansion mutation is thousands of repeats long.
Table 2 DNAscan mode usage recommendations
Type of analysis DNAscan mode
Fast Normal Intensive
SNVs Yes Yes Yes
Small indels (< 50 bps) No No Yes
Structural Variants No Yes Yes
Repeat expansions No Yes Yes
Non-human microbes Yes Yes Yes
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and 40x WGS data was generated with the Illumina
Hiseq X for case B. The WGS sample (paired reads, read
length = 150, average coverage depth = 40) was se-
quenced as part of the Project MinE sequencing dataset
[39]. For this sample we ran DNAscan on the whole
genome. However, both for practical reasons and to
simulate a specific medical diagnostic interest, we fo-
cused our analysis report on the 126 ALS related genes
reported on the ALSoD webserver [47] and also looked
for the C9orf72 repeat.
For both samples, we also reported variants linked to
frontotemporal dementia, which is a neurodegenerative
disease that causes neuronal loss, predominantly involv-
ing the frontal or temporal lobes, with a genetic and
clinical overlap with ALS [48, 49].
C9orf72 repeat primed PCR
Pathological C9orf72 gene hexanucleotide repeat expan-
sions were determined using repeat primed PCR
(RP-PCR), as previously described [50].
Hardware
SpeedSeq was run on a single machine with 64 Gb of
RAM and an Intel i7–670 processor. The other tests
were performed using a machine with 16 Gb of RAM
and an Intel i7–670 processor.
Results
Single nucleotide variant and small indels calling
assessment
To assess the performance of the DNAscan variant call-
ing pipeline with GATK BPW and SpeedSeq, we used
the exome of the well-studied NA12878 sample and the
Illumina platinum calls as a gold standard (our set of
true calls). The SpeedSeq pipeline uses BWA for align-
ment, Sambamba [12] and Samblaster [11] to sort reads
and to remove duplicates, and Freebayes [13] for variant
calling. Considering the overlap in the software used by
DNAscan and SpeedSeq, assessing their performance is
therefore of interest. Figure 2a shows the results from
this test. DNAscan in Fast mode performs comparably
with both the GATK BPW and the SpeedSeq on SNVs.
Their F-measures (Fm), a harmonic mean of precision
and sensitivity defined in the Methods, are 0.92 (DNAS-
can), 0.91 (GATK BPW) and 0.93 (SpeedSeq).
In Normal mode DNAscan (Fm = 0.61) reaches an
indel calling precision and sensitivity comparable to
SpeedSeq (Fm = 0.62). The better performance of the
Normal mode is driven by a major increase in sensitivity
to 0.73 from 0.60. However, GATK BPW outperforms
SpeedSeq on indels (GATK BPW Fm = 0.81). DNAscan,
in Intensive mode, performs comparably to GATK BPW
also on indels with an Fm of 0.82.
Figure 2b shows a comparison of the time needed by
the tested pipelines and their memory usage. DNAscan
in Fast mode completes the analysis in just 63 min while
SpeedSeq takes over twice the time (132 min) and GATK
BPW 5 times longer (310min). DNAscan in both Nor-
mal and Intensive mode completes the analysis in a rea-
sonable time (Normal 77 min, Intensive 98 min).
DNAscan uses as little as 10.5 Gb RAM in Fast mode,
and 12.9 Gb in Normal and Intensive mode, while
GATK BPW uses 15 Gb and SpeedSeq over 25 Gb.
Screening of ALS patients
For Case A, using the Miseq DNA gene panel, DNAscan
detected 13 SNVs reported to be related to ALS and 4 to
frontotemporal dementia on ClinVar, 6 non-synonymous
variants and 6 variants with a deleteriousness CADD
phred score [51] equal to or higher than 13, meaning
that they are predicted to be in the top 5% most deleteri-
ous substitutions (Table 3). The known pathogenic FUS
SNV rs121909670 was detected. No structural variants
were found. The whole analysis was performed in ~ 30
min using 4 threads.
On the WGS data of Case B, for the selected 126 genes,
DNAscan identified 33 SNVs reported to be related to
ALS and 3 to frontotemporal dementia on ClinVar, 64
non-synonymous variants, 748 variants with a deleterious-
ness CADD phred score equal to or higher than 13, one
60-base-pair insertion, 3 over 100,000-base-pair long dele-
tions and 1 tandem duplication. DNAscan was also able
to detect the known C9orf72 expansion (Table 3). The
whole analysis was performed in ~ 8 h using 4 threads.
Virus scanning
We used DNAscan to detect the presence of viral gen-
etic material in a whole genome sequencing sample of
HIV infected human cells. The DNA sequencing data
was produced using the Illumina Hiseq 2000 sequencer
generating about 350 million 95-base length paired
reads. Following the well-established approach of com-
putational subtraction of human host sequences to iden-
tify sequences of infectious agents like viruses [52], the
human reads (91%, Fig. 3a) were subtracted by mapping
the sequencing data to the reference human genome
using HISAT2. To screen our sequencing sample for the
presence of known viral DNA, HISAT2 was then used to
map the unmapped reads from the initial mapping phase
of the pipeline (9%, Fig. 3a) to all the viral genomes
available on the NCBI virus database.
Figure 3c shows a logarithmic representation of the
number of reads aligned to the viral genomes in de-
scending order for the 20 viral genomes to which the
highest number of reads were mapped. They show both
the presence of HIV DNA and bacterial DNA in our
sample. Indeed, 4,412,255 reads mapped to the human
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immunodeficiency virus (NCBI id NC_001802.1) and
only the Escherichia virus phiX174 (NCBI id
NC_001422.1), a bacterial virus, presented a comparable
number of reads (4,834,017 reads). This phage sequence
is commonly found in Illumina sequencing protocols
[53] probably because of transfer from gut microbes into
blood.
Also, a smaller (3–4 orders of magnitude) number of
reads belonging to other viruses were found. The dispro-
portion between the presence of the first two hits
(phiX174 and HIV) and the rest of the viruses is also
shown in Fig. 3b. The complete results with the list of
the whole set of viruses (120 viruses) for which at least
one read was aligned can be found on GitHub [54]. The
whole screening was performed by DNAscan using 4
threads in 2 h.
Discussion and conclusion
DNAscan is an extremely fast, computationally efficient,
easy to use pipeline for analysis, annotation and visual-
isation of next generation DNA sequencing data. It uses
fast, but suboptimal tools to carry out first-line analysis,
and optimal, but slower tools to refine the results. As a
result, DNAscan is faster but not resource hungry, for
example it is able to analyse 40x WGS data in 13 h and
whole exome sequence data in one hour on a mid-range
A
B
Fig. 2 Variant calling assessment. Graph a shows the precision, sensitivity and F-measure of DNAscan in Fast, Normal and Intensive mode,
SpeedSeq and GATK best practice workflow in calling SNVs and small indels over the whole exome sequencing of NA12878. Illumina platinum
calls were used as true positives. The first three columns show the results for SNVs and the last three columns for indels. Graph b shows the time
needed and the memory footprint for the same pipelines
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computer, performing as well as the widely used GATK
BPW in terms of variant calling precision and sensitivity.
Three different running modes, Fast, Normal and Inten-
sive allow the pipeline to be tailored to specific needs
while reducing time and RAM requirements compared
to current standards, GATK BPW and SpeedSeq. It in-
cludes utilities for user friendly visualisation and inter-
pretation of output. It is able to identify SNVs, structural
variants, indels and expansion mutations, and favours
use by non-specialists, and those with limited access to
high performance computing facilities, for example, in
less well-resourced countries or laboratories.
This comprehensive analysis approach aims to maxi-
mise the potential audience of users. However, NGS data
can be used to investigate a very wide range of genetic
variations which are impossible to enclose in only one
analysis pipeline. DNAscan does not provide specific
tools and protocols to detect whole classes of mutations,
for example microsatellites, retrotransposons, novel or
highly irregular repeat expansions and somatic variants.
Moreover, it does not offer the adequate flexibility to
allow different analysis approaches, for example consen-
sus and meta variant calling that have been shown to be
powerful strategies to detect SNVs and structural vari-
ants [55, 56] , or to analyse long-reads sequencing data
such as PacBio and Nanopore [57, 58]. New implemen-
tations of DNAscan are already underway and will in-
clude new analysis protocols, including the detection of
structural variants using long-read sequencing, the de-
velopment of a webserver for an on-the-fly and a graph-
ical user interface. However, the use of highly flexible
and interactive analysis frameworks such as
Seven-Bridges (www.sevenbridges.com), Galaxy [59], or
ExScalibur [60] will remain a necessity for those users
who need a higher degree of flexibility.
We also reported a few specific-use cases, such as the
analysis of Miseq and WGS data of someone with ALS
for diagnostic purposes, and the virus screening of HIV
infected human cells. In the ALS test we showed how
with MiSeq and Hiseq X WGS data, DNAscan detected
a range of reported ALS-related variants in half an hour
for the Miseq panel and 8 h for the WGS data (restrict-
ing the analysis to the 126 ALS genes), correctly report-
ing the presence of both the C9orf72 expansion and the
rs121909670 SNV. In the HIV test, DNAscan detected
the expected viral presence by finding both the HIV
virus and a phage commonly present in Illumina next
generation DNA sequencing data.
Table 3 Analysis of two ALS patients
Case A Case B
Analysis time (minutes) 30 460
Data size (MBs) 40 70,000
N. of ALS-related variants 13 33
N. of FTD-related variants 4 3
N. of non-synonymous variants 6 64
N. of variants with CADD> 13 6 748
N. long insertions 0 1
N. long deletions 0 3
N. Duplications 0 1
N. Inversions 0 0
C9orf72 expansion – Yes
rs121909670 Yes –
Case A was sequenced with targeted MiSeq ALS gene panel and carries a
pathogenic non-synonymous mutation (rs21909670) in the FUS gene. Case B
was whole-genome sequenced and carries a pathogenic C9orf72 expansion
Fig. 3 Identification of non-human reads Panel a shows the proportion of human reads (blue), viral reads (red) and unknown reads (yellow).
Panel b shows the proportion for viral reads belonging to HIV (blue), PhiX174 (red) and to other viruses (yellow). Human reads are defined as
reads which aligned to the human reference genome, viral reads as the reads which did not align to the human reference genome but aligned
to at least one of the NCBI viral genomes and unknown reads as the reads which did not align either to the human or to any viral reference
genomes. In panel c we plotted the numbers of aligned reads in logarithmic scale, for the 20 non-human microbe genomes to which the
highest number of reads was aligned
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Cloud computing and storage services offer practically
unlimited computational power and storage. However,
this has a cost, and optimisation, in particular for large
scale sequencing projects, is of primary importance.
Amazon Web Services (AWS) is one of the most popu-
lar cloud computing services. Performing the alignment,
variant calling and annotation using DNAscan Fast
mode on an EC2 instance [61] would cost about $2.41
(13 h of usage of a t2.xlarge machine with 4 CPUs). The
same analysis using SpeedSeq would cost about $18.72
(10 h of usage of a h1.8xlarge machine with 32 CPUs).
These prices do not take into account the storage, were
updated on the 29th of April 2019 and take into consid-
eration the cheapest machines available in the US East
(Ohio) region matching the pipeline computational re-
quirements proposed by the authors (4 CPUs and 16 Gb
RAM for DNAscan and 32 CPUs and 128 Gb RAM for
SpeedSeq [4]).
DNAscan is also available as a Docker and a Singular-
ity image. These allow the user to quickly and reliably
deploy the pipeline on any machine where either of
these programmes is available. Singularity also allows for
the deployment of the pipeline on environments for
which the user does not have root permission. This
could be particularly useful for users working on shared
high performance computing facilities.
Availability and requirements
Project name: DNAscan
Project home page: https://github.com/KHP-Informat-
ics/DNAscan
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Additional file
Additional file 1: Table S1. Alignment assessment results. HISAT2, BWA
and Bowtie2 were tested on 150 million simulated Illumina paired end
human reads and 1.250 billion real Illumina paired end human reads. For
the three aligners on the two dataset the table shows the time taken,
their memory fingerprint and the percentage of aligned-one-or-more-
times reads, aligned-only-once reads and properly pared. All tests were
run using 4 threads. (DOCX 19 kb)
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